Targeting cancer through enhanced tumor visualization
Employees: 11-50
Total raised: $30.2M
Founded date: 2013
Investors 1
| Date | Name | Website |
| - | Colle Capi... | colle.vc |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 19.10.2022 | Series B | $21.5M | - |
| 12.06.2018 | Series A | $8.7M | - |
Mentions in press and media 11
| Date | Title | Description |
| 17.01.2024 | Vergent Bioscience to Present New Efficacy Results from Phase 2 Clinical Trial of VGT-309 at Annual Meeting of The Society of Thoracic Surgeons | - |
| 19.10.2022 | Vergent Bioscience Secures $21.5 Million Series B Financing to Advance Clinical Development of Tumor-Targeted Fluorescent Imaging Agent VGT-309 | - |
| 04.10.2022 | Vergent Bioscience Secures $21.5M Series B | MINNEAPOLIS, MN, Vergent Bioscience, a clinical-stage biotechnology company, announced the close of a $21.5 million Series B financing. >> Click here for more funding data on Vergent Bioscience >> To export Vergent Bioscienc... |
| 04.10.2022 | Vergent Bioscience Raises $21.5M in Series B Financing | Vergent Bioscience, a Minneapolis, MN-based clinical-stage biotechnology company, raised $21.5M in Series B funding. The round, which brings the total raised by Vergent to date to $34m, was led by Orlando Health Ventures, with participation... |
| 04.10.2022 | Vergent Bioscience makes biotech to spot tumors; it just raised $21.5 million | - |
| 04.10.2022 | Vergent Bioscience Secures $21.5 Million Series B Financing | - |
| 10.04.2022 | Vergent Bioscience Secures $21.5 Million Series B Financing | - |
| 12.06.2018 | Vergent Bioscience Raises $8.7M in Series A Financing | Vergent Bioscience, a Minneapolis-based cancer-focused biotechnology company, raised $8.7m in Series A financing. The round was led by Spring Mountain Capital. The company intends to use the funds to advance its preclinical and clinical dev... |
| 12.06.2018 | Vergent Bioscience Completes $8.7M Series A | MINNEAPOLIS, MN, Vergent Bioscience, a cancer-focused biotechnology company, announced today that it raised $8.7 million in a Series A financing round. >> Click here for more funding data on Vergent Bioscience >> To export V... |
| - | Vergent Bioscience | “Targeting cancer through enhanced tumor visualization” |
Show more